Key Details
Price
$13.47Annual ROE
530.42%Beta
-4.19Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with IZTC included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Invizyne Technologies Common Stock doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of Invizyne Technologies Common Stock?
- What is the ticker symbol for Invizyne Technologies Common Stock?
- Does Invizyne Technologies Common Stock pay dividends?
- What sector is Invizyne Technologies Common Stock in?
- What industry is Invizyne Technologies Common Stock in?
- What country is Invizyne Technologies Common Stock based in?
- Is Invizyne Technologies Common Stock in the S&P 500?
- Is Invizyne Technologies Common Stock in the NASDAQ 100?
- Is Invizyne Technologies Common Stock in the Dow Jones?
- When does Invizyne Technologies Common Stock report earnings?
What is the primary business of Invizyne Technologies Common Stock?
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
What is the ticker symbol for Invizyne Technologies Common Stock?
The ticker symbol for Invizyne Technologies Common Stock is NASDAQ:IZTC
Does Invizyne Technologies Common Stock pay dividends?
No, Invizyne Technologies Common Stock does not pay dividends
What sector is Invizyne Technologies Common Stock in?
Invizyne Technologies Common Stock is in the Healthcare sector
What industry is Invizyne Technologies Common Stock in?
Invizyne Technologies Common Stock is in the Biotechnology industry
What country is Invizyne Technologies Common Stock based in?
Invizyne Technologies Common Stock is headquartered in United States
Is Invizyne Technologies Common Stock in the S&P 500?
No, Invizyne Technologies Common Stock is not included in the S&P 500 index
Is Invizyne Technologies Common Stock in the NASDAQ 100?
No, Invizyne Technologies Common Stock is not included in the NASDAQ 100 index
Is Invizyne Technologies Common Stock in the Dow Jones?
No, Invizyne Technologies Common Stock is not included in the Dow Jones index
When does Invizyne Technologies Common Stock report earnings?
The date for Invizyne Technologies Common Stock's next earnings report has not been announced yet